Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Bradykinin and Epinephrine

supplement:

Epinephrine

Research Papers that Mention the Interaction

In turn, both of the vasoactive peptides of these systems, bradykinin and angiotensin II, stimulate epinephrine production from the adrenal medulla.
Annals of the New York Academy of Sciences  •  1982  |  View Paper
The possibility of bradykinin being a mediator in the coronary vasodilation produced by epinephrine has been discussed.
Circulation research  •  1962  |  View Paper
The underlying mechanism in HAE is related to bradykinin dysregulation which causes these attacks not to respond to common treatment strategies including epinephrine/corticosteroid or adrenaline.
Iranian journal of allergy, asthma, and immunology  •  2021  |  View Paper
With the use of fluorescent Ca(2+) dye, it was found that epinephrine and isoprenaline, a beta-adrenoceptor agonist, induced endothelial Ca(2+) influx in the presence of bradykinin.
Journal of molecular and cellular cardiology  •  2008  |  View Paper
Chronically elevated levels of epinephrine , occurring after vagotomy, desensitize peripheral β2‐adrenergic receptors and lead to enhancement of bradykinin hyperalgesia.
The European journal of neuroscience  •  2003  |  View Paper
Bradykinin significantly reduced the incidence of ectopic beats and epinephrine increased the incidence of nonsustained runs of VT.
Journal of pharmacological and toxicological methods  •  1999  |  View Paper
The SCC response to bradykinin and acetylcholine are attenuated with prior stimulation by 10 microM‐adrenaline.
The Journal of physiology  •  1992  |  View Paper
Bradykinin increased dose-dependently norepinephrine and epinephrine release, particularly when converting enzyme was inhibited.
Journal of cardiovascular pharmacology  •  1992  |  View Paper
bradykinin increased dose dependently the noradrenaline and adrenaline release in particular when the converting enzyme was inhibited.
Agents and actions. Supplements  •  1992  |  View Paper
The α/β‐adrenoceptor agonist adrenaline (100 μg kg−1) caused modest inhibition of leakage induced by BK , but not of the leakage response to PAF.
British journal of pharmacology  •  1991  |  View Paper
Show More